CERK and posterior cortical atrophy: Therefore, as lipogenesis and lipid metabolism play a pivotal role in PCa progression by fueling membrane material and steroid hormone precursors, MALAT1 targeting might represent a potential RNA-based therapy in combination with third-generation AR antagonists by affecting CHKA/SGMS (Kennedy pathway) and CERK/Ceramide metabolism.